• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20010 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2014     NIHR Health Technology Assessment programme Systematic review to identify and appraise outcome measures used to evaluate childhood obesity treatment interventions (CoOR): evidence of purpose, application, validity, reliability and sensitivity
2008     Health Services Assessment Collaboration (HSAC) Systematic review update and economic evaluation for the New Zealand setting: Subcutaneous insulin pump therapy.
2009     Health Services Assessment Collaboration (HSAC) Systematic review update: 64-slice or higher computed tomography angiography in the investigation of patients with suspected coronary artery disease
2013     NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome
2015     NIHR Health Technology Assessment programme Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis
2004     Andalusian Health Technology Assessment Area (AETSA) Systematic review: evaluation methodology of health services based on telemedicine and e-health
2009     VA Technology Assessment Program (VATAP) Systematic reviews for amyotrophic lateral sclerosis
2009     VA Technology Assessment Program (VATAP) Systematic reviews for localized prostate cancer
2009     VA Technology Assessment Program (VATAP) Systematic reviews for nurse-led primary care
2007     VA Technology Assessment Program (VATAP) Systematic reviews for patient-centered care
2010     VA Technology Assessment Program (VATAP) Systematic reviews for patient-centered care: update
2009     VA Technology Assessment Program (VATAP) Systematic reviews for podiatry
2001     NIHR Health Technology Assessment programme Systematic reviews of (i) comparative studies of depot neuroleptic drugs, and (ii) studies of oral vs depot neuroleptic agents for patients with schizophrenia: clinical, social and economic outcomes- systematic review
2014     NIHR Health Technology Assessment programme Systematic reviews of and integrated report on the quantitative, qualitative and economic evidence base for the management of obesity in men
2006     NIHR Health Technology Assessment programme Systematic reviews of clinical decision tools for acute abdominal pain
2012     Center for Evidence-based Practice (CEP) Systematic reviews of robot-assisted surgery: update
2013     Center for Evidence-based Practice (CEP) Systematic reviews of robotic surgery in obstetrics and gynecology
2010     Center for Evidence-based Practice (CEP) Systematic reviews of robotic-assisted surgery
2007     VA Technology Assessment Program (VATAP) Systematic reviews of strategies for changing clinician behavior to improve patient outcomes
2010     VA Technology Assessment Program (VATAP) Systematic reviews of strategies for changing clinician behavior to improve patient outcomes
2007     NIHR Health Technology Assessment programme Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007     NIHR Health Technology Assessment programme Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2001     NIHR Health Technology Assessment programme Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) Acute day hospital versus admission; (2) Vocational rehabilitation; (3) Day hospital versus outpatient care
1998     NIHR Health Technology Assessment programme Systematic reviews of trials and other studies
1999     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (2) Dressings and topical agents used in the healing of chronic wounds
2000     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration
2001     NIHR Health Technology Assessment programme Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy
2010     Agency for Healthcare Research and Quality (AHRQ) Systematic reviews on selected pharmacogenetic tests for cancer treatment: CYP2D6 for Tamoxifen in breast cancer, KRAS for anti-EGFR antibodies in colorectal cancer, and BCR-ABL1 for tyrosine kinase inhibitors in chronic myeloid leukemia
2005     Andalusian Health Technology Assessment Area (AETSA) Systemic active immunotherapy for the treatment of malignant glioma
1996     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Systemic thrombolytics in acute ischemic stroke
2011     Center for Evidence-based Practice (CEP) Systems for early warning of patient deterioration
2002     Agency for Healthcare Research and Quality (AHRQ) Systems to rate the strength of scientific evidence
2002     NIHR Horizon Scanning Centre (NIHR HSC) T-20 for HIV - horizon scanning review
2008     Institute for Clinical Effectiveness and Health Policy (IECS) T-cell vaccines for the treatment of multiple sclerosis
2014     NIHR Health Technology Assessment programme T-DM1 for treating HER2-positive, unresectable locally advanced or metastatic breast cancer after treatment with trastuzumab and a taxane
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) T-score as a measurement to assess the 10-year fracture risk: a review of the clinical evidence
2010     Adelaide Health Technology Assessment (AHTA) T-Stat for the detection of ischaemia
2009     Adelaide Health Technology Assessment (AHTA) T-Stat system for the detection of tissue ischemia
2014     Malaysian Health Technology Assessment (MaHTAS) T.SPOT.TB assay – an update
2013     NIHR Horizon Scanning Centre (NIHR HSC) T30 neurostimulator device for chronic tonal subjective tinnitus
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tabalumab for systemic lupus erythematosus
2000     VA Technology Assessment Program (VATAP) Tablet splitting
2016     NIHR Health Technology Assessment programme Tackling obesity in areas of high social deprivation: clinical effectiveness and cost-effectiveness of a task-based weight management group programme a randomised controlled trial and economic evaluation
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tacrolimus
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®)
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®) for the prophylaxis of transplant rejection in adult kidney or liver allograft recipients and the treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Envarsus®)
1997     Wessex Institute for Health Research and Development (WIHRD) Tacrolimus after kidney transplantation
2004     Quality Improvement Scotland (NHS QIS ) Tacrolimus and pimecrolimus for atopic eczema
2004     National Institute for Health and Clinical Excellence (NICE) Tacrolimus and pimecrolimus for atopic eczema
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Tacrolimus for Crohn's disease
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tacrolimus ointment for the treatment of atopic dermatitis
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus prolonged-release (Advagraf®)
2002     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) TACTICS: Transfusion Associated Complications or Transfusion Induced Complications - primary research
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Tactile devices in audiology
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Tactile devices in audiology
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tadalafil (Cialis) for Duchenne muscular dystrophy
2010     NIHR Horizon Scanning Centre (NIHR HSC) Tafamidis for transthyretin amyloid polyneuropathy
2013     HAYES, Inc. Tai chi for improving balance and function in patients with parkinson's disease
2015     NIHR Horizon Scanning Centre (NIHR HSC) Talazoparib for locally advanced and/or metastatic breast cancer with germline BRCA 1/2 positive mutation
2016     HAYES, Inc. Talimogene laherparepvec (T-VEC; Imlygic) for treatment of unresectable melanoma lesions
2007     Adelaide Health Technology Assessment (AHTA) Tam Pap for self testing of HPV
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tamaflu (R) (oseltamivir phosphate)
1999     ECRI Tamoxifen for reduction of breast cancer incidence in healthy women at high risk
2011     HAYES, Inc. Tandem autologous peripheral blood stem cell transplantation for neuroblastoma
2015     HAYES, Inc. Tandem autologous stem cell transplant for Hodgkin lymphoma
2007     HAYES, Inc. Tandem mass spectrometry for metabolic disease screening of newborns
2002     HAYES, Inc. Tandem mass spectrometry for metabolic screening of newborns
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tap water home haemodialysis systems for end stage renal failure: horizon scanning technology briefing
2009     NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) for severe acute pain
2009     NIHR Horizon Scanning Centre (NIHR HSC) Tapentadol (Palexia) prolonged-release for severe chronic pain
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tapentadol prolonged release (Palexia® SR)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Taranabant (MK-0364) for obesity
2007     NIHR Horizon Scanning Centre (NIHR HSC) Tarenflurbil (Flurizan, R-Flurbiprofen) for Alzheimer’s disease – mild
2020     Institute for Clinical and Economic Review (ICER) Targeted immune modulators for ulcerative colitis: effectiveness and value
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Targeted radionuclide therapy with 90Y- and 177-Lu-DOTATOC in patients with neuroendocrine tumors
2008     Adelaide Health Technology Assessment (AHTA) Targeted screening for abdominal aortic aneurysm
2010     Adelaide Health Technology Assessment (AHTA) Targeted screening for cardiovascular risk for all adults between 40-74 years
2020     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with hormonal therapy as a first-line treatment for HR+ and HER2- metastatic breast cancer
2021     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with neoadjuvant chemotherapy for HER2-positive breast cancer and economic evaluation
2014     NIHR Health Services and Delivery Research programme Targeting the Use of Reminders and Notifications for Uptake by Populations (TURNUP): a systematic review and evidence synthesis
2022     NIHR Health Technology Assessment programme Targeting vascular adhesion protein-1 (VAP-1) for the treatment of liver fibrosis: a study of efficacy and mechanisms in patients with primary sclerosing cholangitis (PSC)
2022     NIHR Health Technology Assessment programme TARGIT-B: An international randomised controlled trial to compare targeted intra-operative radiotherapy boost with conventional external beam radiotherapy boost after lumpectomy for breast cancer in women with a high risk of local recurrence
2006     NIHR Horizon Scanning Centre (NIHR HSC) Taribavirin hydrochloride for chronic hepatitis C virus: horizon scanning review
2010     NIHR Horizon Scanning Centre (NIHR HSC) Taspoglutide for type 2 diabetes mellitus - add-on therapy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tasquinimod for chemotherapy naïve, metastatic hormone-relapsed prostate cancer
2001     NIHR Health Technology Assessment programme Taxanes (breast cancer): update
2001     NIHR Health Technology Assessment programme Taxanes (ovarian cancer): update
2007     NIHR Health Technology Assessment programme Taxanes for the adjuvant treatment early breast cancer: systematic review and economic evaluation
2007     NIHR Health Technology Assessment programme Taxanes for the adjuvant treatment early breast cancer: systematic review and economic evaluation
2000     HAYES, Inc. Taxol treatment for breast cancer
2000     HAYES, Inc. Taxol treatment for non-small-cell lung cancer
2000     HAYES, Inc. Taxol treatment for ovarian cancer
2011     HAYES, Inc. Tay-Sachs Disease (TSD) testing in individuals of non–ashkenazi jewish origin
2011     HAYES, Inc. Taylor spatial frame (Smith&Nephew Inc.) for posttraumatic lower limb deformity
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tc-99m labelled antibody fragment for osteomyelitis
2014     Health Quality Ontario (HQO) Team-based models for end-of-life care: an evidence-based analysis
2012     HAYES, Inc. Tearlab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2011     HAYES, Inc. TearLab osmolarity system (TearLab Corp.) for diagnosis of dry eye disease
2001     HAYES, Inc. Technetium-99m depreotide scintigraphy for detection of pulmonary malignancy